Offices of Biotechnology and Business Development


Welcome to the Offices of Biotechnology and Business Development's website.

 GSK’s Discovery Partnerships with Academia (DPAc) has announced a new “Call for Proposals” for the Fast Track Challenge.   

More information about the GSK Fast Track Challenge can be found here..  


Please submit a short, non-confidential proposal to Einstein's Office of Biotechnology (, NO LATER than  April 15th, 2015

The Office of Biotechnology is looking forward to receiving your non-confidential proposal for this opportunity.  Please contact us at 718-430-3357  if you have any questions. 



GSK DPAc is a new approach to early drug discovery that is designed to provide industrial drug discovery resources and expertise to academic researchers. The focus is on projects that have a specific and testable drug development hypothesis that, if successful, would deliver therapeutic benefit to patients. (All disease indications, treatment modalities and stages of development will be considered.) 

More information about the GSK DPAc program can be found here. 






Richard Kosman (Director, Office of Business Development at Einstein) will be  hosting regularly scheduled "Office Hours" at Montefiore on the second Friday of the month from 9am - 11am in the second floor conference room at 3308 Rochambeau Avenue, Bronx, NY for  "drop-in" office hours. During these hours, Richard will be available to discuss the Technology Commercialization Initiative at Montefiore and how it relates to your research.  If you would like to set up a specific time with Richard, please contact the office to set an appointment.     


This site will serve as a communication tool for the faculty and staff of Albert Einstein College of Medicine, as well as our industry partners. The office of biotechnology serves as the technology transfer office of the college, facilitating the licensing of college technology to industry and research collaborations between industry and faculty. The office of business development serves to further enhance the value of the college's research, clinical and intellectual property assets by proactively collaborating with the commercial, governmental, financial and entrepreneurial communities in novel initiatives. Together, the offices work in partnership and build upon each other’s strengths, in order to fulfill the mission of assisting the translation of basic research advances made at Einstein into clinical applications that can benefit the public. 

The Albert Einstein College of Medicine retains assignment of all patents granted to its faculty. The college, through its Patent Committee, provides a mechanism for internal peer review and encouragement for its faculty to pursue patenting of technologies that are novel and have clear-cut, practical applications in biology and medicine. These applications have broad utility in biotechnology, clinical diagnostics and pharmaceutical medicine. The college is interested in promoting industry-sponsored research on our campus and the commercial development of products derived from our research activities.  

Information about our policies on patenting and working with industrial partners can be found on this site, as well as technologies available for licensing and our contact information. We look forward to working with you.


Contact Us


Offices of Biotechnology and Business Development
1300 Morris Park Avenue
Room 908, Belfer Building
Bronx, NY 10461
Tel: 718.430.3357
Fax: 718.430.8938 


Click here to log in